Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Assessing the antioxidant, cytotoxic, apoptotic and wound healing properties of silver nanoparticles green-synthesized by plant extracts.

Ahn EY, Jin H, Park Y.

Mater Sci Eng C Mater Biol Appl. 2019 Aug;101:204-216. doi: 10.1016/j.msec.2019.03.095. Epub 2019 Mar 26.

PMID:
31029313
2.

Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract.

Lee YJ, Ahn EY, Park Y.

Nanoscale Res Lett. 2019 Apr 11;14(1):129. doi: 10.1186/s11671-019-2967-1.

3.

Green synthesis and biological activities of silver nanoparticles prepared by Carpesium cernuum extract.

Ahn EY, Jin H, Park Y.

Arch Pharm Res. 2019 Oct;42(10):926-934. doi: 10.1007/s12272-019-01152-x. Epub 2019 Apr 10.

PMID:
30972559
4.

Fabrication of nanoribbons by dielectrophoresis assisted cold welding of gold nanoparticles on mica substrate.

Cha SH, Kang SH, Lee YJ, Kim JH, Ahn EY, Park Y, Cho S.

Sci Rep. 2019 Mar 6;9(1):3629. doi: 10.1038/s41598-019-40248-8.

5.

Association between fever pattern and clinical manifestations of adult-onset Still's disease: unbiased analysis using hierarchical clustering.

Kim MJ, Ahn EY, Hwang W, Lee Y, Lee EY, Lee EB, Song YW, Park JK.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):74-79. Epub 2018 Nov 14.

6.
7.

Upcycling of jellyfish (Nemopilema nomurai) sea wastes as highly valuable reducing agents for green synthesis of gold nanoparticles and their antitumor and anti-inflammatory activity.

Ahn EY, Hwang SJ, Choi MJ, Cho S, Lee HJ, Park Y.

Artif Cells Nanomed Biotechnol. 2018;46(sup2):1127-1136. doi: 10.1080/21691401.2018.1480490. Epub 2018 Jul 26.

PMID:
30047294
8.

Highly stable gold nanoparticles green-synthesized by upcycling cartilage waste extract from yellow-nose skate (Dipturus chilensis) and evaluation of its cytotoxicity, haemocompatibility and antioxidant activity.

Ahn EY, Lee YJ, Choi SY, Im AR, Kim YS, Park Y.

Artif Cells Nanomed Biotechnol. 2018;46(sup2):1108-1119. doi: 10.1080/21691401.2018.1479710. Epub 2018 Jun 29.

PMID:
29956560
9.

Fever and Debilitating Myalgia.

Ahn EY, Park JK.

J Clin Rheumatol. 2018 May 11. doi: 10.1097/RHU.0000000000000820. [Epub ahead of print] No abstract available.

PMID:
29757803
10.

An aqueous extract of Nomura's jellyfish ameliorates inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells and a zebrafish model of inflammation.

Hwang SJ, Ahn EY, Park Y, Lee HJ.

Biomed Pharmacother. 2018 Apr;100:583-589. doi: 10.1016/j.biopha.2018.01.116. Epub 2018 Feb 28.

PMID:
29500959
11.

Asymmetric dumbbell-shaped silver nanoparticles and spherical gold nanoparticles green-synthesized by mangosteen (Garcinia mangostana) pericarp waste extracts.

Park JS, Ahn EY, Park Y.

Int J Nanomedicine. 2017 Sep 14;12:6895-6908. doi: 10.2147/IJN.S140190. eCollection 2017.

12.

Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.

Yoo JE, Kim YJ, Rhee H, Kim H, Ahn EY, Choi JS, Roncalli M, Park YN.

PLoS One. 2017 Jan 23;12(1):e0170465. doi: 10.1371/journal.pone.0170465. eCollection 2017.

13.

Catalytic reduction of 4-nitrophenol with gold nanoparticles synthesized by caffeic acid.

Seo YS, Ahn EY, Park J, Kim TY, Hong JE, Kim K, Park Y, Park Y.

Nanoscale Res Lett. 2017 Dec;12(1):7. doi: 10.1186/s11671-016-1776-z. Epub 2017 Jan 5.

14.

Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis.

Park JK, Kim JY, Moon JY, Ahn EY, Lee EY, Lee EB, Cho KH, Song YW.

Arthritis Res Ther. 2016 Dec 30;18(1):306. doi: 10.1186/s13075-016-1204-x.

15.

Green Synthesis and Catalytic Activity of Gold Nanoparticles Synthesized by Artemisia capillaris Water Extract.

Lim SH, Ahn EY, Park Y.

Nanoscale Res Lett. 2016 Dec;11(1):474. Epub 2016 Oct 26.

16.

De Novo Mutations in SON Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing an Intellectual-Disability Syndrome.

Kim JH, Shinde DN, Reijnders MRF, Hauser NS, Belmonte RL, Wilson GR, Bosch DGM, Bubulya PA, Shashi V, Petrovski S, Stone JK, Park EY, Veltman JA, Sinnema M, Stumpel CTRM, Draaisma JM, Nicolai J; University of Washington Center for Mendelian Genomics, Yntema HG, Lindstrom K, de Vries BBA, Jewett T, Santoro SL, Vogt J; Deciphering Developmental Disorders Study, Bachman KK, Seeley AH, Krokosky A, Turner C, Rohena L, Hempel M, Kortüm F, Lessel D, Neu A, Strom TM, Wieczorek D, Bramswig N, Laccone FA, Behunova J, Rehder H, Gordon CT, Rio M, Romana S, Tang S, El-Khechen D, Cho MT, McWalter K, Douglas G, Baskin B, Begtrup A, Funari T, Schoch K, Stegmann APA, Stevens SJC, Zhang DE, Traver D, Yao X, MacArthur DG, Brunner HG, Mancini GM, Myers RM, Owen LB, Lim ST, Stachura DL, Vissers LELM, Ahn EYE.

Am J Hum Genet. 2016 Sep 1;99(3):711-719. doi: 10.1016/j.ajhg.2016.06.029. Epub 2016 Aug 18.

17.

Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.

Park JK, Yang JA, Ahn EY, Chang SH, Song YW, Curtis JR, Lee EB.

BMC Cancer. 2016 Jul 4;16:381. doi: 10.1186/s12885-016-2444-5.

18.

SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes.

Kim JH, Baddoo MC, Park EY, Stone JK, Park H, Butler TW, Huang G, Yan X, Pauli-Behn F, Myers RM, Tan M, Flemington EK, Lim ST, Ahn EY.

Mol Cell. 2016 Mar 17;61(6):859-73. doi: 10.1016/j.molcel.2016.02.024.

19.

Relapsed Brucellosis Presenting as Neurobrucellosis with Cerebral Vasculitis in a Patient Previously Diagnosed with Brucellar Spondylitis: A Case Report.

Kim EJ, Lee SJ, Ahn EY, Ryu DG, Choi YH, Kim TH.

Infect Chemother. 2015 Dec;47(4):268-71. doi: 10.3947/ic.2015.47.4.268. Epub 2015 Dec 30.

20.

ErbB2-intronic microRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling.

Schmitt DC, Madeira da Silva L, Zhang W, Liu Z, Arora R, Lim S, Schuler AM, McClellan S, Andrews JF, Kahn AG, Zhou M, Ahn EY, Tan M.

Cell Death Dis. 2015 May 7;6:e1742. doi: 10.1038/cddis.2015.116.

21.

Thrombotic Complications during Interventional Lung Assist: Case Series.

Kim EJ, Cho WH, Ahn EY, Ryu DG, Lee SE, Jeon DS, Kim YS, Son BS, Kim DH.

Tuberc Respir Dis (Seoul). 2015 Jan;78(1):18-22. doi: 10.4046/trd.2015.78.1.18. Epub 2015 Jan 29.

22.

Transcript variants of RUNX1T1: new insight into t(8;21)-positive leukemia.

Kim JH, Ahn EY.

Leuk Res. 2014 Sep;38(9):1018-9. doi: 10.1016/j.leukres.2014.06.023. Epub 2014 Jul 8. No abstract available.

PMID:
25052308
23.

Increased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients.

Ahn EY, Yoo JE, Rhee H, Kim MS, Choi J, Ko JE, Lee JS, Park YN.

J Transl Med. 2014 May 31;12:154. doi: 10.1186/1479-5876-12-154.

24.

Structural characterization of cyclosporin A, C and microbial bio-transformed cyclosporin A analog AM6 using HPLC-ESI-ion trap-mass spectrometry.

Ahn EY, Shrestha A, Hoang NH, Huong NL, Yoon YJ, Park JW.

Talanta. 2014 Jun;123:89-94. doi: 10.1016/j.talanta.2014.01.067. Epub 2014 Feb 8.

PMID:
24725868
25.

New discoveries of old SON: a link between RNA splicing and cancer.

Hickey CJ, Kim JH, Ahn EY.

J Cell Biochem. 2014 Feb;115(2):224-31. doi: 10.1002/jcb.24672.

PMID:
24030980
26.

Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry.

Kim JS, Kim CH, Chun KJ, Kim JH, Park YH, Kim J, Choi JH, Lee SH, Kim EJ, Yu DG, Ahn EY, Jeong MH.

Clin Res Cardiol. 2013 Dec;102(12):915-22. doi: 10.1007/s00392-013-0611-0. Epub 2013 Aug 28.

PMID:
23982468
27.

RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma.

Ahn EY, Kim JS, Kim GJ, Park YN.

Mol Cancer Res. 2013 Jul;11(7):748-58. doi: 10.1158/1541-7786.MCR-12-0665. Epub 2013 Apr 17.

28.

Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential.

DeKelver RC, Yan M, Ahn EY, Shia WJ, Speck NA, Zhang DE.

Blood. 2013 May 2;121(18):3714-7. doi: 10.1182/blood-2012-11-465641. Epub 2013 Feb 20.

29.

Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML.

Lo MC, Peterson LF, Yan M, Cong X, Jin F, Shia WJ, Matsuura S, Ahn EY, Komeno Y, Ly M, Ommen HB, Chen IM, Hokland P, Willman CL, Ren B, Zhang DE.

Blood. 2012 Aug 16;120(7):1473-84. doi: 10.1182/blood-2011-12-395335. Epub 2012 Jun 26.

30.

A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.

Seok JY, Na DC, Woo HG, Roncalli M, Kwon SM, Yoo JE, Ahn EY, Kim GI, Choi JS, Kim YB, Park YN.

Hepatology. 2012 Jun;55(6):1776-86. doi: 10.1002/hep.25570.

PMID:
22234953
31.

Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.

Matsuura S, Yan M, Lo MC, Ahn EY, Weng S, Dangoor D, Matin M, Higashi T, Feng GS, Zhang DE.

Blood. 2012 Mar 29;119(13):3155-63. doi: 10.1182/blood-2011-04-350694. Epub 2012 Jan 5.

32.

Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.

Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS, Park YN.

Hepatology. 2011 Nov;54(5):1707-17. doi: 10.1002/hep.24559.

PMID:
22045674
33.

SON controls cell-cycle progression by coordinated regulation of RNA splicing.

Ahn EY, DeKelver RC, Lo MC, Nguyen TA, Matsuura S, Boyapati A, Pandit S, Fu XD, Zhang DE.

Mol Cell. 2011 Apr 22;42(2):185-98. doi: 10.1016/j.molcel.2011.03.014.

34.

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

Pawar P, Ma L, Byon CH, Liu H, Ahn EY, Jhala N, Arnoletti JP, McDonald JM, Chen Y.

Clin Cancer Res. 2009 Feb 15;15(4):1288-96. doi: 10.1158/1078-0432.CCR-08-1150.

35.

RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis.

Yan M, Ahn EY, Hiebert SW, Zhang DE.

Blood. 2009 Jan 22;113(4):883-6. doi: 10.1182/blood-2008-04-153742. Epub 2008 Nov 25.

36.

Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis.

Ahn EY, Yan M, Malakhova OA, Lo MC, Boyapati A, Ommen HB, Hines R, Hokland P, Zhang DE.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17103-8. doi: 10.1073/pnas.0802696105. Epub 2008 Oct 24.

37.

A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.

Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh H, Kim GY, Choi YH, Kim ND.

Cancer Lett. 2008 Oct 18;270(1):77-86. doi: 10.1016/j.canlet.2008.04.038. Epub 2008 Jun 12.

PMID:
18554781
38.

Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.

Dayyani F, Wang J, Yeh JR, Ahn EY, Tobey E, Zhang DE, Bernstein ID, Peterson RT, Sweetser DA.

Blood. 2008 Apr 15;111(8):4338-47. doi: 10.1182/blood-2007-07-103291. Epub 2008 Feb 7.

39.

Cytotoxicity of p-tyrosol and its derivatives may correlate with the inhibition of DNA replication initiation.

Ahn EY, Jiang Y, Zhang Y, Son EM, You S, Kang SW, Park JS, Jung JH, Lee BJ, Kim DK.

Oncol Rep. 2008 Feb;19(2):527-34.

PMID:
18202803
40.

3-Chloro-2,5-dihydroxybenzyl alcohol activates human cervical carcinoma HeLa cell apoptosis by inducing DNA damage.

Zhang Y, Ahn EY, Jiang Y, Kim DK, Kang SG, Wu C, Kang SW, Park JS, Son BW, Jung JH.

Int J Oncol. 2007 Dec;31(6):1317-23.

PMID:
17982657
41.

Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.

Pan G, Ahn EY, Chen Y, Feng G, Reddy V, Jhala NC, McDonald JM.

Int J Oncol. 2007 Oct;31(4):843-50.

PMID:
17786316
42.

Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts.

Peterson LF, Boyapati A, Ahn EY, Biggs JR, Okumura AJ, Lo MC, Yan M, Zhang DE.

Blood. 2007 Aug 1;110(3):799-805. Epub 2007 Apr 5. Review.

43.

Proteome analysis of virulence factor regulated by autoinducer-2-like activity in Escherichia coli O157:H7.

Kim Y, Oh S, Ahn EY, Imm JY, Oh S, Park S, Kim SH.

J Food Prot. 2007 Feb;70(2):300-7.

PMID:
17340862
44.

Mechanism of cell cycle arrest by (8E,13Z,20Z)-strobilinin/(7E,13Z,20Z)-felixinin from a marine sponge Psammocinia sp.

Jiang Y, Ahn EY, Ryu SH, Kim DK, Park JS, Kang SW, You S, Lee BJ, Jung JH.

Oncol Rep. 2005 Oct;14(4):957-62.

PMID:
16142357
45.

Fas binding to calmodulin regulates apoptosis in osteoclasts.

Wu X, Ahn EY, McKenna MA, Yeo H, McDonald JM.

J Biol Chem. 2005 Aug 19;280(33):29964-70. Epub 2005 Jun 17.

46.

Cytotoxicity of psammaplin A from a two-sponge association may correlate with the inhibition of DNA replication.

Jiang Y, Ahn EY, Ryu SH, Kim DK, Park JS, Yoon HJ, You S, Lee BJ, Lee DS, Jung JH.

BMC Cancer. 2004 Sep 30;4:70.

47.

Calmodulin binding to the Fas death domain. Regulation by Fas activation.

Ahn EY, Lim ST, Cook WJ, McDonald JM.

J Biol Chem. 2004 Feb 13;279(7):5661-6. Epub 2003 Oct 31.

49.

IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma.

Ahn EY, Pan G, Vickers SM, McDonald JM.

Int J Cancer. 2002 Aug 1;100(4):445-51.

50.

Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).

Vickers SM, Jhala NC, Ahn EY, McDonald JM, Pan G, Bland KI.

Ann Surg. 2002 Jun;235(6):872-8.

Supplemental Content

Support Center